Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization

By Commenges-Ducos M.   Piault S.   Papaxanthos A.   Ribes C.   Dallay D.   Commenges D.  

Fertility and Sterility, Vol. 78, Iss. 5, 2002-11 ,pp. : 1049-1054

Elsevier

Access to resources Recommend Favorite

Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study

By Westergaard L.G.   Erb K.   Laursen S.B.   Rex S.   Rasmussen P.E.  

Fertility and Sterility, Vol. 76, Iss. 3, 2001-09 ,pp. : 543-549

Elsevier

Access to resources Recommend Favorite

Human menopausal gonadotropin and recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles

By van Wely M.   Westergaard L.G.   Bossuyt P.M.M.   van der Veen F.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1121-1122

Elsevier

Access to resources Recommend Favorite

Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome

By Strehler E.   Abt M.   El-Danasouri I.   De Santo M.   Sterzik K.  

Fertility and Sterility, Vol. 75, Iss. 2, 2001-02 ,pp. : 332-336

Elsevier

Access to resources Recommend Favorite

Recombinant human follicle-stimulating hormone versus urinary-derived human menopausal gonadotropin for controlled ovarian stimulation: the science and art of assisted reproductive technologies

By Kelly E.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1105-1107

Elsevier

Access to resources Recommend Favorite